RT Journal Article SR Electronic T1 p53 gene (Gendicine) and embolisation overcame recurrent hepatocellular carcinoma JF Gut JO Gut FD BMJ Publishing Group Ltd and British Society of Gastroenterology SP 1318 OP 1319 DO 10.1136/gut.2005.069237 VO 54 IS 9 A1 Y S Guan A1 Y Liu A1 X P Zhou A1 X Li A1 Q He A1 L Sun YR 2005 UL http://gut.bmj.com/content/54/9/1318.abstract AB Transcatheter arterial chemoembolisation (TACE) has become the standard treatment for unresectable hepatocellular carcinoma (HCC). However, this method is often unsuccessful. The p53 gene, which is present as a mutant form in many human tumours, is known to have broad spectrum antitumour effects when expressed normally. In this study, we report a 23 year old patient with recurrent HCC who was treated with the p53 gene (Gendicine) combining TACE, which resulted in a good clinical prognosis.